Zonalta (Endoxifen 8mg)

Zonalta contains Endoxifen 8 mg, a selective estrogen receptor modulator (SERM) used primarily in the treatment of breast cancer. It works by blocking estrogen receptors in breast tissue, which can help inhibit the growth of estrogen-dependent tumors. Zonalta is often prescribed for patients who have experienced disease progression on other therapies or as an alternative treatment option. This medication is an important part of a comprehensive cancer treatment plan, aiming to improve patient outcomes and quality of life.